Matches in Nanopublications for { ?s ?p "[The difference in responses of chronic myeloid leukemia (CML) patients to BCR-ABL inhibitors compared to FLT3 mutant AML patients to FLT3 inhibitors may be reflective of treating a single gene disease in CML versus multiply altered gene disease in AML.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 8 of
8
with 100 items per page.
- assertion description "[The difference in responses of chronic myeloid leukemia (CML) patients to BCR-ABL inhibitors compared to FLT3 mutant AML patients to FLT3 inhibitors may be reflective of treating a single gene disease in CML versus multiply altered gene disease in AML.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[The difference in responses of chronic myeloid leukemia (CML) patients to BCR-ABL inhibitors compared to FLT3 mutant AML patients to FLT3 inhibitors may be reflective of treating a single gene disease in CML versus multiply altered gene disease in AML.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP639286.RAwIxi5eK75jkTHbYYRE-9eaCrBZZ80gzpzXt5hlaUISQ130_assertion description "[The difference in responses of chronic myeloid leukemia (CML) patients to BCR-ABL inhibitors compared to FLT3 mutant AML patients to FLT3 inhibitors may be reflective of treating a single gene disease in CML versus multiply altered gene disease in AML.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP639286.RAwIxi5eK75jkTHbYYRE-9eaCrBZZ80gzpzXt5hlaUISQ130_provenance.
- assertion description "[The difference in responses of chronic myeloid leukemia (CML) patients to BCR-ABL inhibitors compared to FLT3 mutant AML patients to FLT3 inhibitors may be reflective of treating a single gene disease in CML versus multiply altered gene disease in AML.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP580845.RA9r-IG1qGGyzigPeNgterMtLOznS2osTBMrHPE6vmBus130_assertion description "[The difference in responses of chronic myeloid leukemia (CML) patients to BCR-ABL inhibitors compared to FLT3 mutant AML patients to FLT3 inhibitors may be reflective of treating a single gene disease in CML versus multiply altered gene disease in AML.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP580845.RA9r-IG1qGGyzigPeNgterMtLOznS2osTBMrHPE6vmBus130_provenance.
- NP580846.RA1dcImoxB8Dnvnd4eDoTanjOTf4NSUaimaUqwyS2qo90130_assertion description "[The difference in responses of chronic myeloid leukemia (CML) patients to BCR-ABL inhibitors compared to FLT3 mutant AML patients to FLT3 inhibitors may be reflective of treating a single gene disease in CML versus multiply altered gene disease in AML.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP580846.RA1dcImoxB8Dnvnd4eDoTanjOTf4NSUaimaUqwyS2qo90130_provenance.
- NP580847.RAdyYX5JogiOck2GGLYz7XKjsrjDN6Hv2vrVaCf0s59JQ130_assertion description "[The difference in responses of chronic myeloid leukemia (CML) patients to BCR-ABL inhibitors compared to FLT3 mutant AML patients to FLT3 inhibitors may be reflective of treating a single gene disease in CML versus multiply altered gene disease in AML.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP580847.RAdyYX5JogiOck2GGLYz7XKjsrjDN6Hv2vrVaCf0s59JQ130_provenance.
- NP580848.RAi754E32uqhdRxtUSbSrDpVe2OZyXlxTEGCtyBe7sZZw130_assertion description "[The difference in responses of chronic myeloid leukemia (CML) patients to BCR-ABL inhibitors compared to FLT3 mutant AML patients to FLT3 inhibitors may be reflective of treating a single gene disease in CML versus multiply altered gene disease in AML.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP580848.RAi754E32uqhdRxtUSbSrDpVe2OZyXlxTEGCtyBe7sZZw130_provenance.